Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Clinics and Research in Hepatology and Gastroenterology|April 14, 2021
Prevalence and prognosis of microsatellite instability in oesogastric adenocarcinoma, NORDICAP 16-01My-Linh Tran-Minh, Jacqueline Lehmann-Che, Jerôme Lambert, et al.
Breast (Edinburgh, Scotland)|October 1, 2013
p53 in breast cancer subtypes and new insights into response to chemotherapyPhilippe Bertheau, Jacqueline Lehmann-Che, Mariana Varna, et al.
International Journal of Cancer|December 3, 2008
p53 dependent cell-cycle arrest triggered by chemotherapy in xenografted breast tumorsMariana Varna, Jacqueline Lehmann-Che, Elisabeth Turpin, et al.
Cancer Research|August 29, 2020
Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast CancerPiotr Przanowski, Song Lou, Rachisan Djiake Tihagam, et al.
Cancer Research|May 18, 2012
Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade gliomaHana Janouskova, Anne Maglott, David Y Leger, et al.
Anticancer Research|March 2, 2018
COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer PatientsPatricia DE Cremoux, Anne-Sophie Hamy, Jacqueline Lehmann-Che, et al.
Haematologica|September 7, 2019
Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemiaNabih Maslah, Norman Salomao, Louis Drevon, et al.
Molecular Oncology|January 28, 2014
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancersBalázs Győrffy, Giulia Bottai, Jacqueline Lehmann-Che, et al.
Analytical Chemistry|June 9, 2026
Breast Cancer Diagnosis and HER2+ Versus Triple Negative Discrimination by Infrared Spectral HistopathologyHayat El Tahech, Cédric Lerévérend, Seydou Kane, et al.
Cancers|February 13, 2025
Metabolic Heterogeneity in Diffuse Large B-Cell Lymphoma Cells Reveals an Innovative Antimetabolic Combination StrategyLeonardo Lordello, Stéphanie Nuan-Aliman, Karoline Kielbassa-Elkadi, et al.
Pageof 8